Skip to content
10-Q

Quarterly Report

BIONOVATE TECHNOLOGIES CORP.

0001640334-20-002927

← back to feed
Filed
Nov 23, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Oct 26, 2020 59.42M sh
Long Term Debt Q1 2021 · Sep 30, 2020 $0
Long Term Debt Q1 2021 · Jun 30, 2020 $0
Cash And Equivalents Q1 2021 · Sep 30, 2020 $0
Cash And Equivalents Q1 2021 · Sep 30, 2019 $0
Cash And Equivalents Q1 2021 · Jun 30, 2019 $0
Current Liabilities Q1 2021 · Sep 30, 2020 $419.54K
Current Liabilities Q1 2021 · Jun 30, 2020 $396.67K
Total Liabilities Q1 2021 · Sep 30, 2020 $419.54K
Total Liabilities Q1 2021 · Jun 30, 2020 $396.67K
Current Assets Q1 2021 · Sep 30, 2020 $0
Current Assets Q1 2021 · Jun 30, 2020 $0
Total Assets Q1 2021 · Sep 30, 2020 $0
Total Assets Q1 2021 · Jun 30, 2020 $0
Operating Cash Flow Q1 2021 · Sep 30, 2019 $0
Stockholders Equity Q1 2021 · Sep 30, 2019 −$361.14K
Stockholders Equity Q1 2021 · Jun 30, 2019 −$332.29K
Net Income Q1 2021 · Sep 30, 2019 −$29.38K
Operating Income Q1 2021 · Sep 30, 2019 −$13.41K
Revenue Q1 2021 · Sep 30, 2019 $0